Lorazepam Improvement in Wilson’s Disease Catatonia Did Not Replace the Copper-Metabolism Diagnosis

Written by

in

Symptom improvement after a benzodiazepine does not establish that the underlying illness is purely psychiatric.

What the supplied research shows

A report described an adolescent with catatonia who was subsequently diagnosed with Wilson’s disease through clinical findings, imaging and copper-related investigations. Catatonic symptoms improved after lorazepam, while the longer course included disease-directed therapy and other medicines.

What it cannot establish

A single case with combined treatment cannot establish comparative effectiveness or the contribution of every drug. The report also cannot determine how often Wilson’s disease presents this way. A treatment response is not a stand-alone test of the cause of a syndrome.

Forensic interpretation and case review

Forensic interpretation should distinguish relief of a motor or behavioral syndrome from treatment of the underlying disease. Preserve the diagnostic investigations and medication chronology. Do not interpret benzodiazepine responsiveness as proof that neurological disease was absent, or persistent impairment as proof that the sedative was responsible. The case illustrates why clinical response and etiological diagnosis require separate reasoning.

Source and related reading

Source: supplied full-text paper, PMC8611575. Findings are paraphrased; the forensic discussion is an interpretation of the evidence.

Related: Catatonia in Anti-NMDA Receptor Encephalitis Persisted Despite a Clonazepam-Containing Regimen.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *